FDA Grants Breakthrough Status to AI Breast Cancer Risk Tool
A new AI-powered software analyzes mammograms to predict a woman's personalized five-year risk of developing breast cancer, earning the FDA’s Breakthrough Device designation.
mammo CT
mammography CT
